Literature DB >> 35916913

What is new in perioperative dysglycemia?

Micah T Long1, Alexandra L Anderson2, Timothy B Curry2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2022        PMID： 35916913     DOI： 10.1007/s00134-022-06829-4

Source DB:  PubMed          Journal:  Intensive Care Med        ISSN： 0342-4642            Impact factor:   41.787


× No keyword cloud information.
  3 in total

1.  The Effect of a Liberal Approach to Glucose Control in Critically Ill Patients with Type 2 Diabetes: A Multicenter, Parallel-Group, Open-Label Randomized Clinical Trial.

Authors:  Alexis P Poole; Mark E Finnis; James Anstey; Rinaldo Bellomo; Shailesh Bihari; Vishwanath Biradar; Sarah Doherty; Glenn Eastwood; Simon Finfer; Craig J French; Simon Heller; Michael Horowitz; Palash Kar; Peter S Kruger; Matthew J Maiden; Johan Mårtensson; Colin J McArthur; Shay P McGuinness; Paul J Secombe; Antony E Tobin; Andrew A Udy; Paul J Young; Adam M Deane
Journal:  Am J Respir Crit Care Med       Date:  2022-10-01       Impact factor: 30.528

2.  Relative Hypoglycemia and Lower Hemoglobin A1c-Adjusted Time in Band Are Strongly Associated With Increased Mortality in Critically Ill Patients.

Authors:  James S Krinsley; Peter R Rule; Gregory W Roberts; Michael Brownlee; Jean-Charles Preiser; Sherose Chaudry; Krista D Dionne; Camilla Heluey; Guillermo E Umpierrez; Irl B Hirsch
Journal:  Crit Care Med       Date:  2022-02-08       Impact factor: 9.296

3.  Individualised versus conventional glucose control in critically-ill patients: the CONTROLING study-a randomized clinical trial.

Authors:  Julien Bohé; Hassane Abidi; Vincent Brunot; Amna Klich; Kada Klouche; Nicholas Sedillot; Xavier Tchenio; Jean-Pierre Quenot; Jean-Baptiste Roudaut; Nicolas Mottard; Fabrice Thiollière; Jean Dellamonica; Florent Wallet; Bertrand Souweine; Alexandre Lautrette; Jean-Charles Preiser; Jean-François Timsit; Charles-Hervé Vacheron; Ali Ait Hssain; Delphine Maucort-Boulch
Journal:  Intensive Care Med       Date:  2021-09-29       Impact factor: 17.440
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.